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of transaminases in blood serum and presence of anti HCV
and HCVRNA in the blood.
The positive response to alpha-2a interferon therapy was
found in 20 patients. Of them GNB3 gene was determined
in 3 (15%) patients. In the patients resistant to therapy or
with disease recurrence after antiviral therapy GNB3 C825T
allele was revealed in 12 (60%) patients.
According to our investigations we found increase in number
of GNB3 C825T carriers among the patients without response
to the antiviral treatment.
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Background: There is an increasing evidence of a possible
epidemiological link between HCV infection and diabetes.
It is not known whether such a relationship exists in
patients here as well. We, therefore, investigated the
prevalence of HCV infection in diabetic patients in order to
elucidate the presence of a possible association between
the two endemics in this region. We wanted to compare
the prevalence of HCV infection in diabetic patients with a
sample form general population.
Methods: This cross-sectional study was carried out on 550
diabetes patients seen at diabetes clinic at Nishtar Hospital,
Multan during winter 2008. Patients’ diabetic status and HCV
antibody presence were noted. The control group comprised
of 550 volunteer blood donors attending the blood bank of
Nishtar Hospital, Multan during the period of study. Informed
consent was taken before taking the data. Data Analysis was
done using SPSS v16.
Results: The mean age of patients was 47.58 years while
the mean duration of diabetes was 7.02 years. The patients
were predominantly female (55.27%). Out of 550 patients
whose data was gathered, 86 patients were tested positive
for HCV antibody presence as compared to control in whom
45 people were infected with hepatitis C virus infection out
of 550 (OR = 4.60, 95%CI = 3.22 6.57, p < 0.01). No signiﬁcant
association was found between the duration of diabetes and
presence of HCV infection.
Conclusion: Hepatitis C virus infection is highly prevalent
among type 2 diabetic patients as compared to the control
group in this region. The nature of association and the
effects of other confounding factors need to be seen. It
remains to be elucidated how this co morbidity effects
progression of liver disease and diabetes.
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Background: We determined the association between
Chronic liver disease and Gallstones in a representative
sample of adults in Pakistan.
Methods: We included all the consecutive adults with
HCV antibody positive and HBsAg positive, who visited our
hepatology clinic from Jan 2009 to March 2009. We noted
the status and duration of disease, weight, BMI, associated
DM (Diabetes Mellitus), smoking, ethnicity and number of
children in case of women.
Result: There were 344 participants, out of them 289
(84%) were HCV antibody positive and 55 (16%) were HBsAg
positive. Overall prevalence of gallstones was 14.8%. 84.3%
of gallstones were among HCV antibody positive and 15.7%
among HBsAg positive individuals. Gallstones prevalence
increased with age with a predominance in patients of
more than 40 years of age (P value = 0.003). The frequency
of gallstones increased with the duration of liver disease
(P value = 0.05), peak was seen in patients who had chronic
liver disease for 2 4 years.
Conclusion: Chronic liver disease was strongly associated
with gallstones among men but not in women in our study
in Pakistan and gallstone was more common in adults with
increasing age and severity of liver disease.
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Aim: To evaluate the signiﬁcance of HCV core antigen
detection in the determination of the efﬁcacy of HCV
antiviral therapy in China.
Methods: HCV core antigen was measured in sera of 35
chronic hepatitis C patients. Concentrations of HCV core
antigen and HCVRNA were analyzed at 4 time points before,
during and after the end of antiviral therapy.
Results: This study showed that the HCV core antigen
and HCVRNA concentrations in 35 HCV patients were
signiﬁcantly related. Decrease of HCV core antigen and
HCVRNA concentrations at 4th wk, 24th wk, 48th wk
were observed during antiviral therapy. HCV core antigen
at week 24 of therapy was signiﬁcantly lower than at
week 4 (P= 0.000). In contrast, no decrease was observed in
HCVRNA concentrations in the same time (P= 0.303). HCV
core antigen testing may be advantageous in some cases,
especially the negativity of HCV core antigen at week 4 for
prediction of non-response is reliable.
Conclusion: HCV core antigen represents a stable and
sensitive marker of viral replication, can be used to monitor
the clinical efﬁcacy of HCV antiviral therapy.
Author contribution: Wen-Juan Wu and Yun-Zhi Zhang
contributed equally to this work.
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Background: 17% of Mongolian population is infected with
HCV, which makes the country one of the top HCV infected
countries in the world. Though HCV quantiﬁcation method
was developed almost a decade ago it was only in 2009,
when it was ﬁrst introduced in Mongolia.
Method: Total of HCV 212 patients were enrolled in the
study, all of whom had HCV quantiﬁcation at Happy Veritas
clinical laboratory. HCV quantiﬁcation (Taqman real-time
PCR method) was performed by ABI7000. Applied Bio-
systems, USA. Commercially available HCV quantiﬁcation
kit was used in the study. Anti-HCV was purchased from
ACON laboratories, USA.
Result: Out of 212 patients who had HCV quantiﬁed only
35 were also checked for HCV antibody. Patients were
divided in high viral load >2 million HCV copies/ml, and
low-intermediate <2 million HCV copies/ml. we checked for
liver function tests in both groups. Only 3.1% of patients
in the high group had normal liver enzymes (AST< 30 IU),
while 47% had normal liver enzymes in low-intermediate
group. Average ALT 45 IU in low-intermediate group. Mean
